Dana-Farber Cancer Institute has received a USD 50 million philanthropic grant from the Yawkey Foundation to support construction of a planned 300-bed cancer hospital in Boston, the largest single gift in the foundation's eight-decade relationship with the institution.
The grant will fund construction of a 14-floor, 450,000-square-foot facility that Dana-Farber describes as the only dedicated adult cancer hospital in New England. The investment also supports the institute's Future of Cancer Care Fund, directing resources toward early detection research, survivorship programs, psychosocial services, and patient assistance. A connecting bridge spanning Brookline Avenue — linking the existing Yawkey Center for Cancer Care to the new hospital — will be named for Jean and Tom Yawkey, commemorating the family's founding role in the institution's development.
The scale of the gift reflects the ongoing shift in oncology infrastructure financing toward large-scale philanthropic commitments alongside federal and institutional sources. Dana-Farber, a federally designated Comprehensive Cancer Center and Harvard Medical School teaching affiliate, operates more than 1,200 clinical trials and competes for research talent and patients with institutions including Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center.